New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
16:20 EDTSUPNOrchard Hill Capital reports 7.5% stake in Supernus, will continue talks
Orchard Hill has had, and expects to continue to have, discussions with the company’s management and other shareholders regarding ways to maximize shareholder value, including the business, operations, governance, management, strategy, and future plans of the company. However, Orchard Hill now believes it would be beneficial to engage more substantively with the company's management. Orchard Hill may also take further steps including engaging in discussions with shareholders, management, the board and other interested parties regarding such matters as strategic alternatives including exploring a sale of the company.
News For SUPN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 14, 2014
09:08 EDTSUPNSupernus announces Paragraph IV ANDA filing for Trokendi XR
Supernus Pharmaceuticals announced that on October 13, the company received a Paragraph IV Notice Letter from Zydus Pharmaceuticals advising Supernus of the filing by Zydus of an Abbreviated New Drug Application seeking approval for topiramate extended-release capsules. Supernus is currently reviewing the details of this Notice Letter and intends to vigorously enforce its intellectual property rights relating to Trokendi XR. The product is currently protected by three issued patents that are listed in the FDA's Orange Book and expire no earlier than 2027.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use